The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

E.L. Savlevich

Training Scientific Medical Center of the Russian Federation Presidential Administration, Moscow, Russia, 121359

V.S. Kozlov

Kafedra otorinolaringologii FGBU UNMTs UD Prezidenta RF

M.A. Zharkykh

Polyclinic №5 of Department for Presidential Affairs of the Russian Federation, Moscow, Russia, 119121

A study of the efficacy and safety of new cephalosporin in the treatment of acute bacterial rhinosinusitis

Authors:

E.L. Savlevich, V.S. Kozlov, M.A. Zharkykh

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2016;81(6): 73‑77

Views: 4369

Downloaded: 91

To cite this article:

Savlevich EL, Kozlov VS, Zharkykh MA. A study of the efficacy and safety of new cephalosporin in the treatment of acute bacterial rhinosinusitis. Russian Bulletin of Otorhinolaryngology. 2016;81(6):73‑77. (In Russ.)
https://doi.org/10.17116/otorino201681673-77

Recommended articles:
Acute puru­lent otitis media in children. Russian Bulletin of Otorhinolaryngology. 2023;(6):38-41
Drug resi­stance of dermatophytes: do we face the emergence of Indian variants of trichophytosis?. Russian Journal of Clinical Dermatology and Vene­reology. 2023;(2):141-146
Anti­biotic prescription practice in outpatient settings. Russian Journal of Preventive Medi­cine. 2023;(7):30-37
Nimo­dipine in treatment of bipo­lar diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(12):20-26
Topi­cal anti­bacterial therapy of rhinosinusitis. Russian Rhinology. 2024;(1):39-47

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.